Johnson & Johnson stopped its COVID-19 vaccine trial, which began phase 3 testing last month
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9, 2020. This …
Manufacturer Prices for Insulin Substantially Higher in the U.S.
Manufacturer prices more than eight times higher in the U.S. than in other high-income countries
Factors Associated With Suicide in Leukemia Identified
Risk factors include male sex, older age at diagnosis, White race
DKA Episode May Harm Cognitive Function in Children With T1D
Lower IQ and worse memory seen in children with newly diagnosed type 1 diabetes and single event
Reproductive Factors Linked to Cardiovascular Disease in Women
For composite CVD, twofold link seen for preeclampsia, stillbirth, preterm birth; risk lower with longer breastfeeding
Type of Anesthesia Not Linked to Dementia Risk in Older Adults
Dementia risk did not differ by general, regional anesthesia in seniors undergoing elective surgery
Symptoms of COVID-19 Poor Marker for SARS-CoV-2 Infection
Only 13.9 percent of individuals with positive test reported specific symptoms on the day of the test
For Substance Abusers, Odds of Opioid Use Up With Cannabis Use
For adults using nonmedical opioids, odds of opioid use are increased on days when cannabis is used
Exercise Intensity Seems Not to Impact Mortality Levels
Combined MICT, HIIT intervention group had no difference in mortality versus recommended guidelines